Jacques Camerlo

1.2k total citations
50 papers, 932 citations indexed

About

Jacques Camerlo is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Jacques Camerlo has authored 50 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 15 papers in Hematology and 9 papers in Genetics. Recurrent topics in Jacques Camerlo's work include Neutropenia and Cancer Infections (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Cancer Treatment and Pharmacology (9 papers). Jacques Camerlo is often cited by papers focused on Neutropenia and Cancer Infections (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Cancer Treatment and Pharmacology (9 papers). Jacques Camerlo collaborates with scholars based in France and Armenia. Jacques Camerlo's co-authors include Patrice Viens, D Maraninchi, Dominique Genre, Gwénaëlle Gravis, M. Resbeut, François Bertucci, Norbert Vey, Didier Blaise, Réda Bouabdallah and Christel Protière and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jacques Camerlo

49 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Camerlo France 18 448 212 190 172 162 50 932
David Topolsky United States 15 348 0.8× 337 1.6× 127 0.7× 83 0.5× 123 0.8× 39 884
Bart C. Kuenen Netherlands 17 519 1.2× 159 0.8× 176 0.9× 511 3.0× 264 1.6× 31 1.2k
Ulrich‐Peter Rohr Germany 15 513 1.1× 224 1.1× 98 0.5× 285 1.7× 296 1.8× 25 1.2k
Monica Giordano Italy 22 690 1.5× 300 1.4× 214 1.1× 443 2.6× 205 1.3× 93 1.6k
Jaya Ghosh India 18 563 1.3× 108 0.5× 177 0.9× 198 1.2× 284 1.8× 102 1.5k
Hedwig M. Blommestein Netherlands 16 296 0.7× 253 1.2× 64 0.3× 175 1.0× 113 0.7× 62 665
Sacha Satram‐Hoang United States 16 537 1.2× 189 0.9× 37 0.2× 262 1.5× 117 0.7× 48 1.0k
James Hackett United States 16 946 2.1× 195 0.9× 425 2.2× 297 1.7× 103 0.6× 30 1.4k
Kathleen Donohue United States 18 469 1.0× 237 1.1× 42 0.2× 232 1.3× 86 0.5× 36 1.1k
Cheryl Sickles United States 6 266 0.6× 102 0.5× 141 0.7× 58 0.3× 132 0.8× 7 637

Countries citing papers authored by Jacques Camerlo

Since Specialization
Citations

This map shows the geographic impact of Jacques Camerlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Camerlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Camerlo more than expected).

Fields of papers citing papers by Jacques Camerlo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Camerlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Camerlo. The network helps show where Jacques Camerlo may publish in the future.

Co-authorship network of co-authors of Jacques Camerlo

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Camerlo. A scholar is included among the top collaborators of Jacques Camerlo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Camerlo. Jacques Camerlo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blaise, Didier, Jacques Camerlo, Marc Giovannini, et al.. (2021). The Management of a Comprehensive Cancer Center during the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute’s Experience. SHILAP Revista de lepidopterología. 3(4). 119–119. 2 indexed citations
2.
Guérin, Mathilde, Keyvan Rezaï, Nicolás Isambert, et al.. (2017). PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer. European Journal of Cancer. 86. 28–36. 45 indexed citations
3.
Gravis, Gwénaëlle, Christel Protière, François Eisinger, et al.. (2011). Full access to medical records does not modify anxiety in cancer patients. Cancer. 117(20). 4796–4804. 26 indexed citations
4.
Eisinger, François, et al.. (2006). Breast cancer guidelines—Physicians' intentions and behaviors. International Journal of Cancer. 120(5). 1136–1140. 7 indexed citations
5.
Vv, Ivanov, Catherine Faucher, Mohamad Mohty, et al.. (2005). Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation. Bone Marrow Transplantation. 36(10). 901–906. 11 indexed citations
6.
Vv, Ivanov, Catherine Faucher, Mohamad Mohty, et al.. (2004). Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level. Transfusion. 44(4). 501–508. 18 indexed citations
7.
Viret, F., Marc Ychou, A. Gonçalves, et al.. (2003). Docetaxel and Radiotherapy and Pancreatic Cancer. Pancreas. 27(3). 214–219. 15 indexed citations
8.
9.
Genre, Dominique, Christel Protière, Gwénaëlle Gravis, et al.. (2002). Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles. Supportive Care in Cancer. 10(3). 222–230. 9 indexed citations
10.
Protière, Christel, Patrice Viens, Dominique Genre, et al.. (2000). Patient participation in medical decision-making: A French study in adjuvant radio-chemotherapy for early breast cancer. Annals of Oncology. 11(1). 39–46. 44 indexed citations
11.
12.
Viret, F., Didier Blaise, Réda Bouabdallah, et al.. (1999). Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involment. PubMed. 41(1). 5–11. 1 indexed citations
13.
Protière, Christel, Dominique Genre, D. Cowen, et al.. (1997). OP23. Elicitation of preferences and patients participation in the decision making process. European Journal of Cancer. 33. S9–S9. 1 indexed citations
14.
Viens, Patrice, Dominique Genre, M. Resbeut, et al.. (1997). Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care. British Journal of Cancer. 76(12). 1640–1645. 68 indexed citations
15.
Viens, Patrice, Gwénaëlle Gravis, Dominique Genre, et al.. (1997). High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer. Bone Marrow Transplantation. 20(3). 199–203. 14 indexed citations
16.
Stoppa, A.-M., Réda Bouabdallah, Christian Chabannon, et al.. (1997). Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 15(5). 1722–1729. 37 indexed citations
17.
Faucher, Catherine, Anne‐Gaëlle Le Corroller, Christian Chabannon, et al.. (1996). Autologous Transplantation of Blood Stern Cells Mobilized with Filgrastim Alone in 93 Patients with Malignancies: The Number of CD34+ Cells Reinfused Is the Only Factor Predicting Both Granulocyte and Platelet Recovery. Journal of Hematotherapy. 5(6). 663–670. 43 indexed citations
18.
19.
Eberlé, Frédéric, Yves Toiron, Jacques Camerlo, et al.. (1995). Persistence of BCR/ABL mRNA-Expressing Bone-Marrow Cells in Patients with Chronic Myelogenous Leukemia in Complete Cytogenetic Remission Induced by Interferon-alpha Therapy. Leukemia & lymphoma. 18(1-2). 153–157. 2 indexed citations
20.
Xerri, Luc, Réda Bouabdallah, Jacques Camerlo, & J Hassoun. (1994). Expression of the p53 gene in Hodgkin's disease: Dissociation between immunohistochemistry and clinicopathological data. Human Pathology. 25(5). 449–454. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Topolsky Breakdown of academic impact, for papers by Bart C. Kuenen Breakdown of academic impact, for papers by Ulrich‐Peter Rohr Breakdown of academic impact, for papers by Monica Giordano Breakdown of academic impact, for papers by Jaya Ghosh Breakdown of academic impact, for papers by Hedwig M. Blommestein Breakdown of academic impact, for papers by Sacha Satram‐Hoang Breakdown of academic impact, for papers by James Hackett Breakdown of academic impact, for papers by Kathleen Donohue Breakdown of academic impact, for papers by Cheryl Sickles
Rankless by CCL
2026